Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

Main Inclusion Criteria: * Patient (male or female) ≥18 years old * Patient with Open Angle Glaucoma or Ocular Hypertension in both eyes * Informed consent dated and signed. Main Exclusion Criteria: * Secondary Open Agle Glaucoma (ex. Pseudoexfoliation, Pigmentary glaucoma) * Advanced stage of glaucoma * History of ocular trauma, eye infection, or/and ocular clinically significant inflammation within the 6 previous months. * Known or suspected hypersensitivity to one of the components of the IMPs or other product used in the clinical study * Pregnancy (confirmed with a positive urine pregnancy test) or breast-feeding.